Qualified applicants must hold a PhD in an appropriate field (e.g., Human Genetics, Genomics, Pharmacology, Pharmacogenomics, or related fields). A background in cancer pharmacology/pharmacogenomics is also highly desirable. The post-doctoral fellow will have a strong interest in: pharmacogenomic clinical trials, clinical GWAS, NGS of DNA and RNA, gene expression analysis or miRNA analysis, eQTL analysis, and functional validation of SNPs. Demonstrated experience in applying molecular biology theory and techniques to understanding the functional consequences of genetic variation and the implications of variant polymorphisms and haplotypes for individual differences in disease prognosis and therapeutic response is essential. Other key skills include: familiarity with extraction and interpretation of data from genomic and pharmacogenomic repositories (1000 Genomes, NCBI, PharmGKB, ENCODE), ability to work with large datasets, quality assessment and interpretation of data from genotype, microarray, and next generation sequencing platforms, an understanding of PLINK and next generation sequencing alignment tools, as well the flexibility and ability to develop new skills. Understanding of the principles and practice of research using human tissue samples is also highly desirable. Applicants should have exemplary organizational and time management skills, strict attention to detail, and strong interpersonal skills, including the ability to build and maintain positive working relationships with diverse groups including laboratory staff, clinical staff, scientists, and administrative personnel. The qualified candidate will be responsible for performance and documentation of scientific research in consultation with the laboratory PI. Excellent oral and written English, including demonstrated experience in preparing scientific documents is required for this position.